Cryotherapy May Prevent Chemo-Induced Neuropathy
FRIDAY, Oct. 20, 2017 -- Cryotherapy may be useful for preventing symptoms of chemotherapy-induced peripheral neuropathy (CIPN), according to a study published online Oct. 12 in the Journal of the National Cancer Institute.
Akiko Hanai, O.T.R., from Kyoto University in Japan, and colleagues evaluated the efficacy of cryotherapy for CIPN prevention among 36 breast cancer patients treated weekly with paclitaxel (80mg/m2 for one hour). Study participants wore frozen gloves and socks on the dominant side for 90 minutes, including the entire duration of drug infusion.
The incidence of objective and subjective CIPN signs was lower on the intervention side versus the control side. This held true for hand tactile sensitivity (odds ratio [OR], 20; 95 percent confidence interval [CI], 3.2 to 828.96; P < 0.001), foot tactile sensitivity (OR, infinite; 95 percent CI, 3.32 to infinite; P < 0.001), hand warm sense (OR, 9; 95 percent CI, 1.25 to 394.48; P = 0.02), foot warm sense (OR, 5; 95 percent CI, 1.07 to 46.93; P = 0.04), hand Patient Neuropathy Questionnaire (PNQ; OR, infinite; 95 percent CI, 3.32 to infinite; P < 0.001), and foot PNQ (OR, infinite; 95 percent CI, 2.78 to infinite; P < 0.001).
"Cryotherapy is useful for preventing both the objective and subjective symptoms of CIPN and resultant dysfunction," conclude the authors.
© 2020 HealthDay. All rights reserved.
Posted: October 2017
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.